Preclinical and clinical study on [(18)F]DRKXH1: a novel β-amyloid PET tracer for Alzheimer’s disease

BACKGROUND: The deposition of β-amyloid (Aβ) in the brain is a biomarker of Alzheimer’s disease (AD). Highly sensitive Aβ positron emission tomography (PET) imaging plays an essential role in diagnosing and evaluating the therapeutic effects of AD. AIM: To synthesize a new Aβ tracer [(18)F]DRKXH1 (5...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, MiaoMiao, Guo, Jun, Gu, JiaCheng, Zhang, LinLin, Liu, ZiHao, Ding, Lin, Fu, HongLiang, Ma, YuFei, Liang, Sheng, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803783/
https://www.ncbi.nlm.nih.gov/pubmed/34292345
http://dx.doi.org/10.1007/s00259-021-05421-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803783/
https://www.ncbi.nlm.nih.gov/pubmed/34292345
http://dx.doi.org/10.1007/s00259-021-05421-0

Ejemplares similares